In 2018, the three CEO’s listed below are guilty of making large, avoidable mistakes that lead directly to share price carnage. Vic Neufeld, CEO of Aphria (APHA.T) When Vic…
2018
Yield Growth (BOSS.C), a newly public company, has positioned itself to capitalize on the emerging post-farm bill CBD market in 2019. The farm bill, signed by President Trump last week,…
by Guy Bennett Christmas Eve, 2018 – I’m writing this from a hospital bed in a hard scrabble town in the mountains of Yunnan Province, China, called Yong Shan. …
Weed stocks have been in down cycles before, but have always traditionally had sustained periods of irrational exuberance shortly thereafter, so folks would be forgiven for viewing the current…
After an already success-filled year, CUV Ventures (CUV.V) finally crossed a financial goal line with RevoluPAY. RevoluPAY, CUV’s subsidiary, processed its first USD $25,000 worth of bookings for Expedia…
Acreage Pharms, an Invictus MD (GENE.V) subsidiary, entered into a five-year supply and distribution deal with Deutsche Medizinalcannabis for 10,000 kilograms of dried flower. Deutsche Medizinalcannabis is both an…
It’s time to end the charade. Canadian licensed cannabis producer Aphria (APHA.T) has long been considered one of the ‘big three’ in the North American scene, which helped them benefit…
According to a recent Forbes article, “Every thought-leader and hotshot CEO who made it big did so by embracing their niche.” “If you recognize the trends you are good…
Developing hardware is a bitch. According to data from a recent hardware symposium, 85% of polled companies stated that they had missed their product development schedule. Patriot One (PAT.V)…
1933 Industries (TGIF.C) is expanding its Las Vegas-based CBD production facility to meet demand in the post-Farm Bill landscape. The company’s prospects for 2019 are looking bullish as 1933’s…